Tilelizumab

Advanced Non-squamous Non-small Cell Lung Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3

—

Rating in progress

Tilelizumab in Advanced Non-squamous Non-small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active